Immuneering (IMRX) Return on Assets (2021 - 2024)
Immuneering has reported Return on Assets over the past 4 years, most recently at 0.81% for Q3 2024.
- Quarterly results put Return on Assets at 0.81% for Q3 2024, down 37.0% from a year ago — trailing twelve months through Sep 2024 was 0.81% (down 37.0% YoY), and the annual figure for FY2023 was 0.49%, down 14.0%.
- Return on Assets for Q3 2024 was 0.81% at Immuneering, down from 0.69% in the prior quarter.
- Over the last five years, Return on Assets for IMRX hit a ceiling of 0.2% in Q4 2021 and a floor of 0.81% in Q3 2024.
- Median Return on Assets over the past 4 years was 0.44% (2023), compared with a mean of 0.44%.
- Biggest five-year swings in Return on Assets: dropped -9bps in 2022 and later crashed -37bps in 2024.
- Immuneering's Return on Assets stood at 0.2% in 2021, then plummeted by -94bps to 0.4% in 2022, then decreased by -28bps to 0.51% in 2023, then tumbled by -60bps to 0.81% in 2024.
- The last three reported values for Return on Assets were 0.81% (Q3 2024), 0.69% (Q2 2024), and 0.58% (Q1 2024) per Business Quant data.